Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Submit a comment

STARD7 maintains intestinal epithelial mitochondria architecture, barrier integrity, and protection from colitis
Jazib Uddin, Ankit Sharma, David Wu, Sunil Tomar, Varsha Ganesan, Paula E. Reichel, Lakshmi Narasimha Rao Thota, Rodolfo I. Cabrera-Silva, Sahiti Marella, Gila Idelman, Hock L. Tay, Arturo Raya-Sandino, Mack B. Reynolds, Srikanth Elesela, Yael Haberman, Lee A. Denson, Charles A. Parkos, Mary X.D. O’Riordan, Nicholas W. Lukacs, David N. O’Dwyer, Senad Divanovic, Asma Nusrat, Timothy E. Weaver, Simon P. Hogan
Jazib Uddin, Ankit Sharma, David Wu, Sunil Tomar, Varsha Ganesan, Paula E. Reichel, Lakshmi Narasimha Rao Thota, Rodolfo I. Cabrera-Silva, Sahiti Marella, Gila Idelman, Hock L. Tay, Arturo Raya-Sandino, Mack B. Reynolds, Srikanth Elesela, Yael Haberman, Lee A. Denson, Charles A. Parkos, Mary X.D. O’Riordan, Nicholas W. Lukacs, David N. O’Dwyer, Senad Divanovic, Asma Nusrat, Timothy E. Weaver, Simon P. Hogan
View: Text | PDF
Research Article Inflammation

STARD7 maintains intestinal epithelial mitochondria architecture, barrier integrity, and protection from colitis

  • Text
  • PDF
Abstract

Susceptibility to inflammatory bowel diseases (IBDs), Crohn’s disease (CD), and ulcerative colitis (UC) is linked with loss of intestinal epithelial barrier integrity and mitochondria dysfunction. Steroidogenic acute regulatory (StAR) protein-related lipid transfer (START) domain-containing protein 7 (STARD7) is a phosphatidylcholine-specific (PC-specific) lipid transfer protein that transports PC from the ER to the mitochondria, facilitating mitochondria membrane stabilization and respiration function. The aim of this study was to define the contribution of STARD7 in the regulation of the intestinal epithelial mitochondrial function and susceptibility to colitis. In silico analyses identified significantly reduced expression of STARD7 in patients with UC, which was associated with downregulation of metabolic function and a more severe disease phenotype. STARD7 was expressed in intestinal epithelial cells, and STARD7 knockdown resulted in deformed mitochondria and diminished aerobic respiration. Loss of mitochondria function was associated with reduced expression of tight junction proteins and loss of intestinal epithelial barrier integrity that could be recovered by AMPK activation. Stard7+/– mice were more susceptible to the development of DSS-induced and Il10–/– spontaneous models of colitis. STARD7 is critical for intestinal epithelial mitochondrial function and barrier integrity, and loss of STARD7 function increases susceptibility to IBD.

Authors

Jazib Uddin, Ankit Sharma, David Wu, Sunil Tomar, Varsha Ganesan, Paula E. Reichel, Lakshmi Narasimha Rao Thota, Rodolfo I. Cabrera-Silva, Sahiti Marella, Gila Idelman, Hock L. Tay, Arturo Raya-Sandino, Mack B. Reynolds, Srikanth Elesela, Yael Haberman, Lee A. Denson, Charles A. Parkos, Mary X.D. O’Riordan, Nicholas W. Lukacs, David N. O’Dwyer, Senad Divanovic, Asma Nusrat, Timothy E. Weaver, Simon P. Hogan

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts